Experience Scientific Sessions 2024 Final Program 47 XXXX | XXXXX *Not a CE accredited session. Population Science CARDIOMETABOLIC HEALTH AND DIABETES Abstract Oral Session | CM.AOS.01 | The Future of Prevention in Cardiometabolic Disease Saturday, Nov. 16 | 9:45–11:00 a.m. | S102A Abstract Poster Session* | CM.APS.01 | Adiposity in Cardiovascular Risk and Management Saturday, Nov. 16 | 10:30–11:30 a.m. | Zone 3, Science & Technology Hall Moderated Digital Poster Session* | CM.MDP.02 | Prevention Can’t Weight: Emerging Therapeutic Strategies for Obesity and CVD Saturday, Nov. 16 | 12:50–2:15 p.m. | Zone 3, Moderated Digital Poster 15, Science & Technology Hall Moderated Digital Poster Session* | CM.MDP.03 | The Road to Cardiometabolic Disease: Exploring Biological and Social Mechanisms Saturday, Nov. 16 | 12:50–2:15 p.m. | Zone 3, Moderated Digital Poster 12, Science & Technology Hall Cardiovascular Seminar | CM.CVS.01 | Obesity and HFpEF: From Mechanisms to Management Saturday, Nov. 16 | 1:30–2:45 p.m. | N226 Abstract Poster Session* | CM.APS.03 | Novel Glycemic and Lipid Lowering Therapies Saturday, Nov. 16 | 2:00–3:00 p.m. | Zone 3, Science & Technology Hall Abstract Poster Session* | CM.APS.02 | The Pathologic Drivers Underlying Obesity and Diabetes Saturday, Nov. 16 | 2:00–3:00 p.m. | Zone 3, Science & Technology Hall Cardiovascular Seminar | CM.CVS.02 | Optimizing CKM Management in Type 2 Diabetes: A Practical, Case-Based Discussion With Experts Sunday, Nov. 17 | 8:00–9:15 a.m. | N226 Global Roundtable | CM.GRT.02 | Cardiometabolic Factors: Global Burden and Innovative Solutions Sunday, Nov. 17 | 9:45–11:00 a.m. | N136 Moderated Digital Poster Session* | CM.MDP.04 | The Next Stage: CKM Syndrome Progression and Implications for CVD Outcomes Sunday, Nov. 17 | 11:10 a.m.–12:35 p.m. | Zone 3, Moderated Digital Poster 13, Science & Technology Hall Abstract Poster Session* | CM.APS.04 | Deep Dive Into the Relationship Between Obesity and CVD Sunday, Nov. 17 | 11:30 a.m.–12:30 p.m. | Zone 3, Science & Technology Hall Abstract Poster Session* | CM.APS.05 | Exploring the CV Effects and Real-World Usage of GLP1 Receptor Agonists and SGLT2i Sunday, Nov. 17 | 11:30 a.m.–12:30 p.m. | Zone 3, Science & Technology Hall Moderated Digital Poster Session* | CM.MDP.05 | New Frontiers for Optimizing Cardiometabolic Outcomes Sunday, Nov. 17 | 3:15–4:30 p.m. | Zone 3, Moderated Digital Poster 12, Science & Technology Hall Abstract Poster Session* | CM.APS.06 | Translating the Concept of CKM Syndrome to Real-World Populations Sunday, Nov. 17 | 3:15–4:15 p.m. | Zone 3, Science & Technology Hall
RkJQdWJsaXNoZXIy MjI2NjI=